What's the deal with Aduhelm? - a podcast by DW.COM | Deutsche Welle

It's a 'breakthrough' drug for Alzheimer's… but no one's sure if it actually works. There are also clear risks of side effects... and yet it was approved by the top US drug agency (prompting three scientists to quit). What is going on?

Further episodes of Science unscripted

Further podcasts by DW.COM | Deutsche Welle

Website of DW.COM | Deutsche Welle